The Landscape of Genetic Variations in Non-syndromic Primary Ovarian Insufficiency in the MENA Region: a Systematic Review

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 May 13

PMID 38737775

Authors

Asma Allouch

Tara Al-Barazenji

Mashael Al-Shafai

Atiyeh M Abdallah

Affiliations

Soon will be listed here.

Abstract

Introduction: Premature ovarian insufficiency (POI) is a primary cause of infertility with variable clinical manifestations. POI is a multifactorial disease with both environmental and known genetic etiologies, but data on the genetic variations associated with POI in the Middle East and North Africa (MENA) region are scarce. The aim of this study was to systematically review all known genetic causes of POI in the MENA region.

Methods: The PubMed, Science Direct, ProQuest, and Embase databases were searched from inception to December 2022 for all reports of genetic variants associated with POI in the MENA region. Clinical and genetic data were collected from eligible articles, and ClinVar and PubMed (dbSNP) were searched for variants.

Results: Of 1,803 studies, 25 met the inclusion criteria. Fifteen studies were case-control studies and ten were case reports representing 1,080 non-syndromic POI patients in total. Seventy-nine variants in 25 genes associated with POI were reported in ten MENA countries. Of the 79 variants, 46 were rare and 33 were common variants. Of the 46 rare variants, 19 were pathogenic or likely pathogenic according to ACMG classification guidelines and ClinVar. No clear phenotype-genotype association was observed. Male family members carrying pathogenic variants also had infertility problems.

Discussion: To our best knowledge, this is the first systematic review of the genetic variants associated with POI in the MENA region. Further functional studies are needed to assess the disease-causing molecular mechanisms of these variants. Knowledge of the genetic basis of POI in the Middle East could facilitate early detection of the condition and thus early implementation of therapeutic interventions, paving the way for precision medicine options in specific populations.

References

Bouali N, Francou B, Bouligand J, Lakhal B, Malek I, Kammoun M . NOBOX is a strong autosomal candidate gene in Tunisian patients with primary ovarian insufficiency. Clin Genet. 2016; 89(5):608-13. DOI: 10.1111/cge.12750. View

Zangen D, Kaufman Y, Zeligson S, Perlberg S, Fridman H, Kanaan M . XX ovarian dysgenesis is caused by a PSMC3IP/HOP2 mutation that abolishes coactivation of estrogen-driven transcription. Am J Hum Genet. 2011; 89(4):572-9. PMC: 3188834. DOI: 10.1016/j.ajhg.2011.09.006. View

Faienza M, Chiarito M, Baldinotti F, Canale D, Savino C, Paradies G . NR5A1 Gene Variants: Variable Phenotypes, New Variants, Different Outcomes. Sex Dev. 2020; 13(5-6):258-263. DOI: 10.1159/000507411. View

Na J, Kim G . Recent trends in stem cell therapy for premature ovarian insufficiency and its therapeutic potential: a review. J Ovarian Res. 2020; 13(1):74. PMC: 7313218. DOI: 10.1186/s13048-020-00671-2. View

Golezar S, Ramezani Tehrani F, Khazaei S, Ebadi A, Keshavarz Z . The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric. 2019; 22(4):403-411. DOI: 10.1080/13697137.2019.1574738. View

Al-Agha A, Ahmed I, Nuebel E, Moriwaki M, Moore B, Peacock K . Primary Ovarian Insufficiency and Azoospermia in Carriers of a Homozygous PSMC3IP Stop Gain Mutation. J Clin Endocrinol Metab. 2017; 103(2):555-563. PMC: 5800840. DOI: 10.1210/jc.2017-01966. View

Liu H, Wei X, Sha Y, Liu W, Gao H, Lin J . Whole-exome sequencing in patients with premature ovarian insufficiency: early detection and early intervention. J Ovarian Res. 2020; 13(1):114. PMC: 7510158. DOI: 10.1186/s13048-020-00716-6. View

Hamer G, Gell K, Kouznetsova A, Novak I, Benavente R, Hoog C . Characterization of a novel meiosis-specific protein within the central element of the synaptonemal complex. J Cell Sci. 2006; 119(Pt 19):4025-32. DOI: 10.1242/jcs.03182. View

Maor-Sagie E, Cinnamon Y, Yaacov B, Shaag A, Goldsmidt H, Zenvirt S . Deleterious mutation in SYCE1 is associated with non-obstructive azoospermia. J Assist Reprod Genet. 2015; 32(6):887-91. PMC: 4491075. DOI: 10.1007/s10815-015-0445-y. View

10.

Lacombe A, Lee H, Zahed L, Choucair M, Muller J, Nelson S . Disruption of POF1B binding to nonmuscle actin filaments is associated with premature ovarian failure. Am J Hum Genet. 2006; 79(1):113-9. PMC: 1474115. DOI: 10.1086/505406. View

11.

Smirin-Yosef P, Zuckerman-Levin N, Tzur S, Granot Y, Cohen L, Sachsenweger J . A Biallelic Mutation in the Homologous Recombination Repair Gene SPIDR Is Associated With Human Gonadal Dysgenesis. J Clin Endocrinol Metab. 2016; 102(2):681-688. DOI: 10.1210/jc.2016-2714. View

12.

Alavi A, Darki F, Rahimi Bidgoli M, Zare-Abdollahi D, Moini A, Shahshahani M . Mutation in ALOX12B likely cause of POI and also ichthyosis in a large Iranian pedigree. Mol Genet Genomics. 2020; 295(4):1039-1053. DOI: 10.1007/s00438-020-01663-z. View

13.

Huang Q, Chen S, Chen J, Shi Q, Lin S . Therapeutic options for premature ovarian insufficiency: an updated review. Reprod Biol Endocrinol. 2022; 20(1):28. PMC: 8815154. DOI: 10.1186/s12958-022-00892-8. View

14.

Ojeda D, Lakhal B, Fonseca D, Braham R, Landolsi H, Mateus H . Sequence analysis of the CDKN1B gene in patients with premature ovarian failure reveals a novel mutation potentially related to the phenotype. Fertil Steril. 2011; 95(8):2658-60.e1. DOI: 10.1016/j.fertnstert.2011.04.045. View

15.

Ma L, Chen Y, Mei S, Liu C, Ma X, Li Y . Single nucleotide polymorphisms in premature ovarian failure-associated genes in a Chinese Hui population. Mol Med Rep. 2015; 12(2):2529-38. PMC: 4464472. DOI: 10.3892/mmr.2015.3762. View

16.

Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B . ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016; 31(5):926-37. DOI: 10.1093/humrep/dew027. View

17.

Qin Y, Jiao X, Simpson J, Chen Z . Genetics of primary ovarian insufficiency: new developments and opportunities. Hum Reprod Update. 2015; 21(6):787-808. PMC: 4594617. DOI: 10.1093/humupd/dmv036. View

18.

Heddar A, Ogur C, Da Costa S, Braham I, Billaud-Rist L, Findikli N . Genetic landscape of a large cohort of Primary Ovarian Insufficiency: New genes and pathways and implications for personalized medicine. EBioMedicine. 2022; 84:104246. PMC: 9475279. DOI: 10.1016/j.ebiom.2022.104246. View

19.

Huang J, Acharya A, Taglialatela A, Nambiar T, Cuella-Martin R, Leuzzi G . MCM8IP activates the MCM8-9 helicase to promote DNA synthesis and homologous recombination upon DNA damage. Nat Commun. 2020; 11(1):2948. PMC: 7290032. DOI: 10.1038/s41467-020-16718-3. View

20.

Ferrarini E, De Marco G, Orsolini F, Gianetti E, Benelli E, Fruzzetti F . Characterization of a novel mutation V136L in bone morphogenetic protein 15 identified in a woman affected by POI. J Ovarian Res. 2021; 14(1):85. PMC: 8244212. DOI: 10.1186/s13048-021-00836-7. View